Literature DB >> 31423276

MicroRNA-2053 overexpression inhibits the development and progression of hepatocellular carcinoma.

Tao Song1, Ke Ma2, Cui Zhao3, Jijin Yang4, Jingyu Liu4.   

Abstract

MicroRNAs (miRNAs) represent a class of small RNAs that participate in the regulation of tumor progression. However, the identification of functional miRNAs in tumors has not been thoroughly elucidated. In the present study we aim to investigate the impact of altered miR-2053 expression in hepatocellular carcinoma (HCC) cells. The results of the present study demonstrated that miR-2053 overexpression inhibited cell proliferation, migration and invasion, and promoted apoptosis in a HCC cell line, while miR-2053 knockdown induced the opposite cellular phenotypic changes. Mechanistically, it was found that overexpression of miR-2053 resulted in the downregulation of the phosphoinositide 3-kinase (PI3K) and Wnt/β-catenin signaling pathways, which are aberrantly expressed in HCC. Collectively, the results indicate that miR-2053 serves as a tumor suppressor with a crucial role in inhibiting the proliferation, migration and invasion of HCC via targeting the PI3K and Wnt/β-catenin signaling pathways. These data indicate a potential application of miR-2053 in cancer therapy.

Entities:  

Keywords:  Wnt; invasion; microRNA-2053; migration; phosphoinositide 3-kinase; proliferation

Year:  2019        PMID: 31423276      PMCID: PMC6607194          DOI: 10.3892/ol.2019.10501

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  40 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy.

Authors:  F Chang; J T Lee; P M Navolanic; L S Steelman; J G Shelton; W L Blalock; R A Franklin; J A McCubrey
Journal:  Leukemia       Date:  2003-03       Impact factor: 11.528

3.  Molecular pathogenesis of human hepatocellular carcinoma.

Authors:  Snorri S Thorgeirsson; Joe W Grisham
Journal:  Nat Genet       Date:  2002-08       Impact factor: 38.330

Review 4.  Matrix metalloproteinases in tumour invasion and metastasis.

Authors:  S Curran; G I Murray
Journal:  J Pathol       Date:  1999-11       Impact factor: 7.996

Review 5.  The PI3K pathway as drug target in human cancer.

Authors:  Kevin D Courtney; Ryan B Corcoran; Jeffrey A Engelman
Journal:  J Clin Oncol       Date:  2010-01-19       Impact factor: 44.544

6.  Role of PI3K/AKT/mTOR signaling in the cell cycle progression of human prostate cancer.

Authors:  Ning Gao; Zhuo Zhang; Bing-Hua Jiang; Xianglin Shi
Journal:  Biochem Biophys Res Commun       Date:  2003-10-31       Impact factor: 3.575

7.  Hepatocellular carcinoma: management of an increasingly common problem.

Authors:  Gary L Davis; Jane Dempster; James D Meler; Douglas W Orr; Mark W Walberg; Brian Brown; Brian D Berger; John K O'Connor; Robert M Goldstein
Journal:  Proc (Bayl Univ Med Cent)       Date:  2008-07

8.  Involvement of PI3K/PTEN/AKT/mTOR pathway in invasion and metastasis in hepatocellular carcinoma: Association with MMP-9.

Authors:  Jing-Song Chen; Qian Wang; Xin-Hui Fu; Xiao-Hui Huang; Xi-Lin Chen; Liang-Qi Cao; Lian-Zhou Chen; Hao-Xiang Tan; Wen Li; Jiong Bi; Long-Juan Zhang
Journal:  Hepatol Res       Date:  2009-02       Impact factor: 4.288

Review 9.  MicroRNAs involved in tumor suppressor and oncogene pathways: implications for hepatobiliary neoplasia.

Authors:  Justin L Mott
Journal:  Hepatology       Date:  2009-08       Impact factor: 17.425

10.  Functional interaction between Wnt3 and Frizzled-7 leads to activation of the Wnt/beta-catenin signaling pathway in hepatocellular carcinoma cells.

Authors:  Miran Kim; Han Chu Lee; Orkhontuya Tsedensodnom; Rochelle Hartley; Young-Suk Lim; Eunsil Yu; Philippe Merle; Jack R Wands
Journal:  J Hepatol       Date:  2008-02-07       Impact factor: 25.083

View more
  2 in total

1.  LncRNA KCNQ1OT1 inhibits the radiosensitivity and promotes the tumorigenesis of hepatocellular carcinoma via the miR-146a-5p/ACER3 axis.

Authors:  Ganghua Yang; Lijing Zhou; Qinhong Xu; Fandi Meng; Yong Wan; Xiankui Meng; Lin Wang; Lei Zhang
Journal:  Cell Cycle       Date:  2020-09-16       Impact factor: 4.534

2.  Human umbilical cord mesenchymal stem cells-derived exosomal microRNA-451a represses epithelial-mesenchymal transition of hepatocellular carcinoma cells by inhibiting ADAM10.

Authors:  Yunxiuxiu Xu; Yu Lai; Linhui Cao; Yanshan Li; Guangcheng Chen; Liang Chen; Hanqin Weng; Tao Chen; Lingyun Wang; Yibiao Ye
Journal:  RNA Biol       Date:  2020-12-31       Impact factor: 4.652

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.